Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
28 April 2024 - P2521
Cefiderocol either in monotherapy or combination vs best available therapy in the treatment of carbapenem-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis
Lorenzo Onorato, Caterina Monari, Ilaria De Luca, Nicola Coppola
28 April 2024 - P2522
Outcomes at test of cure by baseline pathogen and cefepime-taniborbactam or meropenem MIC in the Phase 3 CERTAIN-1 study of patients with complicated urinary tract infection (cUTI)
Greg Moeck, Leanne Gasink, Mary Beth Dorr, Hongzi Chen, Paul Mcgovern
28 April 2024 - P2523
Real-world effectiveness and safety of cefiderocol in patients with Gram-negative bacterial infections in the early access programme in Spain: results of the PERSEUS study
Paula Ramirez, Esperanza Merino, Jessica Sarda, A. Javier Gonzalez, Stefano Verardi, Jesús Fortún
28 April 2024 - P2524
Real-world effectiveness and safety of long-term (>28 days) cefiderocol treatment in patients with Gram-negative bacterial infections in the PERSEUS study in Spain
Maria Jose Perez-Pedrero, Jorge Calderon-Parra, Sarda Jessica, A. Javier Gonzalez, Stefano Verardi
28 April 2024 - P2525
Effectiveness of cefiderocol in patients with intra-abdominal infections caused by Gram-negative bacteria in the PERSEUS study in Spain
Carmen Maria Saez, Fernando Mateos Rodriguez, Sarda Jessica, A. Javier Gonzalez, Stefano Verardi, Joaquin Lobo Palanco
28 April 2024 - P2526
Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of ANT3310, a novel serine beta-lactamase inhibitor, in healthy volunteers
Christian Zwingelstein, Aline Schindelé, Adeline Ledoux, Sophie Hays, Marc Lemonnier, Magdalena Zalacain
28 April 2024 - P2527
Antimicrobial susceptibility of baseline Neisseria gonorrhoeae isolates from participants recruited in the global zoliflodacin Phase 3 randomised controlled trial
Alison Luckey, Varalakshmi Elango, Esther Bettiol, Laura J. V. Piddock, Magnus Unemo, Patricia Bradford, Sarah Mcleod, John P. Mueller, Subasree Srinivasan
28 April 2024 - P2528
Early symptom response in patients with uncomplicated urinary tract infection treated with gepotidacin or nitrofurantoin: pooled data from two pivotal Phase 3 studies
Keith Kaye, Jason M. Pogue, Jeremy Dennison, Caroline Perry, Chun Huang, Meghan E. Luck, Aruni Mulgirigama, Salim Janmohamed, Amanda J. Sheets
28 April 2024 - P2530
Efficacy of gepotidacin vs nitrofurantoin for uncomplicated urinary tract infections: outcomes in EUCAST-based analysis populations from two Phase 3 noninferiority trials
Florian Wagenlehner, Caroline Perry, Thomas M. Hooton, Jeremy Dennison, Nicole Scangarella-Oman, Deborah Butler, John Breton, Helen Millns, Sarah Watts, Emily Jarvis, Marcy Powell, Salim Janmohamed, Amanda Sheets
28 April 2024 - P2531
Gepotidacin and nitrofurantoin efficacy by baseline uropathogen phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections
Nicole Scangarella-Oman, Deborah Butler, John Breton, Derrek Brown, Cara Kasapidis, Caroline Perry, Jeremy Dennison, Amanda Sheets, Chun Huang, Helen Millns, Salim Janmohamed
28 April 2024 - P2532
In vitro activity of gepotidacin against baseline uropathogenic phenotypes and genotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections
Nicole Scangarella-Oman, Deborah Butler, John Breton, Derrek Brown, Cara Kasapidis, Amanda Sheets
28 April 2024 - P2533
Colistin/meropenem: the impact of synergy on outcomes in the OVERCOME trial
Mariya Huralska, Jason M. Pogue, Hamadullah Shaikh, Michael Rybak, Varduhi Ghazaryan, Keith Kaye
28 April 2024 - P2534
A randomised trial evaluating a novel individualised treatment strategy for carbapenem-resistant Gram-negative infections
Jocelyn Teo, Ying Ying Ong, Anne-Marie Govindasamy, Zhi Wei Ong, Tze-Peng Lim, Winnie Lee, Yiying Cai, Candice Yuen Yue Chan, Yvonne Fu Zi Chan, Benjamin Pei-Zhi Cherng, Piotr Chlebicki, Ying Ying Chua, Shimin Jasmine Chung, Cherie Le Si Gan, Shirin Kalimuddin, Mei Ling Kang, Jenny Guek Hong Low, Hui Lin Dorothy Ng, Jean Xiang Ying Sim, Ban Hock Tan, Sophie Seine Xuan Tan, Thuan Tong Tan, Yii Ean Teh, Siew Yee Thien, Indumathi Venkatachalam, Limin Wijaya, Liang En Ian Wee, Anson Hei Man Wong, Tse Hsien Koh, David Chien Boon Lye, Andrea Lay-Hoon Kwa
28 April 2024 - P2535
Normobaric oxygen therapy augments killing of slow growing Pseudomonas aeruginosa by quinolones
Mette Kolpen, Thomas Bryrup, Daniel Faurholt-Jepsen, Tavs Qvist, Thomas Bjarnsholt, Tacjana Pressler, Ole Hyldegaard, Mads Lichtenberg, Peter Østrup Jensen,
28 April 2024 - P2536
Efficacy of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the United States (CACTUS) among immunocompromised patients
Ryan K. Shields, Lilian Abbo, Renee Ackley, Samuel L. Aitken, Benjamin Albrecht, Ahmed Babiker, Esther Bae, Renzo Cifuentes, Kimberly Claeys, Brooke Curry, Kathryn Desear, Jason Gallagher, Eric Gregory, Alan Gross, Emily L. Heil, Carissa Hickey, Trieu-Vi Khuu, Megan Klatt, Ellen G. Kline, Ryan Kubat, Wesley D. Kufel, Jae Hyoung Lee, Ahmi Lim, Theresa Lingg, Conan Macdougall, Amy Mathers, Erin K. Mccreary, Marguerite Monogue, William Justin Moore, Shannon Olson, Jessica Oxer, Jeffrey C. Pearson, Christine Pham, Paulette Pinargote-Cornejo, Christopher Polk, Michael Satlin, Sarah Satola, Sunish Shah, Yash B. Solanki, Pranita Tamma, David Van Duin, Mollie Vannatta, Ana Vega, Veena Venugopalan, Michael Veve, Walaiporn Wangchinda, Lucy S. Witt, Janet Wu, Jason M. Pogue
28 April 2024 - P2537
Pivmecillinam for oral transition therapy in Gram-negative bacteraemia
Neil Stevenson, Sean Coyle, Laura Ciaccio, Charis Marwick, Nikolas Rae
28 April 2024 - P2538
Efficacy of cefiderocol for the treatment of Stenotrophomonas maltophilia infections: a case series from the SUSANA cohort
Marco Fois, Francesca Cherchi, Elena Ricci, Nicolò Corti, Alessandra Bandera, Benedetto Maurizio Celesia, Vincenzo Boscia, Francesco Luzzaro, Paolo Bonfanti, Giordano Madeddu
28 April 2024 - P2539
Dalbavancin in the treatment of osteoarticular infections: real-world data from the Italian cohort SUSANA
Luca Mezzadri, Ester Pollastri, Elena Ricci, Giuseppe Vittorio De Socio, Sara Tordi, Vincenzo Boscia, Benedetto Maurizio Celesia, Giordano Madeddu, Marco Fois, Paolo Maggi, Francesca Colucci, Michele Bartoletti, Goffredo Angioni, Luca Bisi, Marianna Rossi, Paolo Bonfanti
28 April 2024 - P2540
Dalbavancin as consolidation therapy of enterococcal infective endocarditis: preliminary results of Spanish-French cohort
Carmen Hidalgo Tenorio, Svetlana Sadyrbaeva-Dolgova, Eduardo Aparicio-Miguijon, Antonio Plata, Arístides De Alarcón, Francisco Javier Martinez, Belen Alvarez-Alvarez, Romaric Larcher, Florent Valour, Belen Loeches, Nahéma Issa, Pauline Thill, Jose Maria Miro, Benedetta Varisco, Agustin Estevez-Prieto, Sophie Nguyen, Samantha Poloni Samantha Poloni, Carmen Herrero, Francesc Escrihuela-Vidal, Lucía Boix-Palop, Romain Millot, Marc Fabre, Nathan Peiffer-Smadja, Timothée Boyer, Yvon Yvon Ruch, David Luque Paz
28 April 2024 - P2541
Real-world use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics)
Sara Tordi, Elena Ricci, Luca Mezzadri, Luca Bisi, Veronica Gonzi, Martina Tegon, Giordano Madeddu, Letizia Attala, Stefania Piconi, Goffredo Angioni, Paolo Maggi, Benedetto Maurizio Celesia, Daniela Francisci, Paolo Bonfanti, Giuseppe Vittorio De Socio
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.